Scarica l'app Stockscreener
13.91
1.16%
0.16
Precedente Chiudi:
$13.75
Aprire:
$13.79
Volume 24 ore:
89,445
Relative Volume:
0.55
Capitalizzazione di mercato:
$161.29M
Reddito:
$42.16M
Utile/perdita netta:
$-14.38M
Rapporto P/E:
-7.7709
EPS:
-1.79
Flusso di cassa netto:
$-9.90M
1 W Prestazione:
+3.81%
1M Prestazione:
-10.72%
6M Prestazione:
+140.24%
1 anno Prestazione:
+354.58%
Intervallo 1D:
$13.68
$13.94
Intervallo di 1 settimana:
$13.35
$13.94
Portata 52W:
$2.951
$17.31
Lensar Inc Stock (LNSR) Company Profile
Nome
Lensar Inc
Settore
Industria
Telefono
888-536-7271
Indirizzo
2800 DISCOVERY DRIVE, ORLANDO
Confronta LNSR con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
LNSR
Lensar Inc
|
13.91 | 161.29M | 42.16M | -14.38M | -9.90M | -1.79 |
|
ABT
Abbott Laboratories
|
130.98 | 221.92B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
95.12 | 139.43B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
346.50 | 134.90B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
82.60 | 108.02B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
71.53 | 40.93B | 5.72B | 4.17B | 259.90M | 6.97 |
Lensar Inc Stock (LNSR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2021-02-24 | Iniziato | SVB Leerink | Outperform |
Lensar Inc Borsa (LNSR) Ultime notizie
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: LENSAR, Inc. (NasdaqLNSR), 180 Degree Capital Corp. (Nasdaq – TURN), Dun & Bradstreet Holdings, Inc. (NYSEDNB), Global Blue Group Holding AG (N - TradingView
Is LENSAR (LNSR) a Deeply Undervalued Stock? - Insider Monkey
Trading (LNSR) With Integrated Risk Controls - news.stocktradersdaily.com
Taxation With Representation: Norton Rose, Latham, Ashurst - Law360
Lake Street Capital Reiterates "Hold" Rating for LENSAR (NASDAQ:LNSR) - MarketBeat
Alcon Inc’s Acquisition of LENSAR Inc - Global Legal Chronicle
Related Content: Alcon to Acquire LENSAR | Business | Mar 2025 - Photonics Spectra
Alcon to buy Lensar in deal worth up to $430M - The Business Journals
Alcon to Acquire LENSAR | Business | Mar 2025 - Photonics Spectra
ALC Stock Rises Following the Merger Agreement With LENSAR - MSN
Alcon signs merger agreement to acquire Lensar - MSN
LENSAR INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of LENSAR, Inc.LNSR - Business Wire
Bernstein maintains Alcon Outperform rating, $110.50 target By Investing.com - Investing.com UK
Alcon lines up Lensar deal to expand laser cataract surgery options - Optics.org
BTIG Research Downgrades LENSAR to Neutral From Buy - MarketScreener
Alcon agrees to purchase LENSAR - Ophthalmology Times
Switzerland: Alcon agrees acquisition of Lensar for up to US$430m - Investors in Healthcare
LENSAR’s (LNSR) “Hold” Rating Reaffirmed at Lake Street Capital - Defense World
Alcon Agrees to Acquire Lensar, Inc. for Up to $430 Million - VisionMonday.com
BTIG cuts LENSAR stock rating post Alcon acquisition deal - Investing.com India
BTIG cuts LENSAR stock rating post Alcon acquisition deal By Investing.com - Investing.com Australia
$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of LENSAR, Inc.LNSR - The Malaysian Reserve
Latham & Watkins Represents LENSAR, Inc. in Acquisition by Alcon - Latham & Watkins LLP
Alcon to Acquire LENSAR in $430M Deal - USA Herald
Alcon to acquire Lensar for up to $430M - BioWorld MedTech
Norton Rose, Latham Steer Alcon's $430M Lensar Buy - Law360
Alcon agrees to acquire LENSAR for $14.00 per share - MSN
Alcon to acquire LENSAR for up to $430 million By Investing.com - Investing.com South Africa
Alcon to Acquire Lensar for up to $430 million. - MD+DI
SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of LENSAR, Inc. (LNSR) - TradingView
Alcon Agrees to Acquire LENSAR, Inc. - sharewise.com
Alcon Buys MedTech Company LENSAR - themiddlemarket.com
Lake Street Downgrades LENSAR to Hold From Buy, Price Target is $15 -March 24, 2025 at 11:54 am EDT - Marketscreener.com
Alcon Eyes Surgical Edge With LENSAR Buyout: Details - Benzinga
Switzerland's Alcon to Buy US-based Medical Technology Group Lensar -March 24, 2025 at 09:48 am EDT - Marketscreener.com
Shareholder Alert: The Ademi Firm Investigates Whether LENSAR, Inc. is Obtaining a Fair Price for Its Public Shareholders - Business Wire
LNSR Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of LENSAR, Inc. Is Fair to Shareholders - Bluefield Daily Telegraph
Alcon to Buy Lensar for up to $430 Million - MPO-mag
Alcon to Acquire Lensar for $430 Million -March 24, 2025 at 08:42 am EDT - Marketscreener.com
Alcon to acquire LENSAR for up to $430 million - Investing.com
LENSAR Announces Merger Agreement with Alcon - TipRanks
Alcon Agrees To Acquire LENSAR For Up To Approximately $430 Mln - Nasdaq
Alcon Agrees To Acquire Lensar, Inc. -March 24, 2025 at 08:03 am EDT - MarketScreener
Major Medical Tech Deal: Alcon Acquires Robotic Surgery Pioneer LENSAR for $430M - Stock Titan
LENSAR, Inc. (NASDAQ:LNSR) Shares Purchased by Atria Investments Inc - Defense World
LENSAR Announces Application for Certification of the ALLY Adaptive Cataract Treatment System in the EU - Business Wire
LENSARTop Healthcare Equipment Stock - Inkl
Lensar Inc Azioni (LNSR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.01%
0.46%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):